John Trizzino - Jun 25, 2023 Form 4 Insider Report for NOVAVAX INC (NVAX)

Role: EVP, CCO and CBO
Signature: /s/ John A. Herrmann III, Attorney-in-Fact
Stock symbol: NVAX
Transactions as of: Jun 25, 2023
Transactions value $: -$2,700
Form type: 4
Date filed: 6/27/2023, 04:32 PM
Previous filing: Mar 14, 2023
Next filing: Aug 22, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVAX	Common Stock	Options Exercise		+833	+9.19%		9.89K	Jun 25, 2023	Direct	F1
transaction	NVAX	Common Stock	Tax liability	-$2.7K	-403	-4.07%	$6.70	9.49K	Jun 25, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVAX	Restricted Stock Units	Options Exercise	$0	-833	-100%	$0.00^*	0	Jun 25, 2023	Common Stock	833		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
F2	The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the June 25, 2020 grant date, in each case subject to continued employment with the Company through such vesting date.